BioCentury
ARTICLE | Company News

Management tracks

April 16, 2015 2:23 AM UTC

Merck KGaA (Xetra:MRK) said Udit Batra will become head of its combined life sciences business, pending completion in mid-2015 of its planned acquisition of Sigma-Aldrich Corp. (NASDAQ:SIAL). Batra has been CEO and president of Merck KGaA's life science business since March 2014. Sigma-Aldrich President and CEO Rakesh Sachdev will remain in his role until the acquistion closes.

Blood disorder company Global Blood Therapeutics Inc. (South San Francisco, Calif.) named Jung Choi CBO. Choi was SVP of corporate development at InterMune Inc., which Roche (SIX:ROG; OTCQX:RHHBY) acquired. ...